Australia's most trusted
source of pharma news
Saturday, 12 July 2025
Posted 27 November 2024 PM
Tributes are pouring in from across industry following the death of Russell Conley who stepped down as the CEO of the GI Cancer Institute in September after 22 years with the organisation - sadly succumbing to the disease he spent his entire career fighting.
Conley received his diagnosis two years ago, undergoing gruelling treatments but remaining in his beloved job for as long as he could to help patients, finally stepping down less than two months ago for health reasons.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.